中华超声影像学杂志
中華超聲影像學雜誌
중화초성영상학잡지
CHINESE JOURNAL OF ULTRASONOGRAPHY
2014年
11期
957-961
,共5页
陈琮瑛%王文韬%余蓉%袁鹰%李胜利%杨霞%王恩礼
陳琮瑛%王文韜%餘蓉%袁鷹%李勝利%楊霞%王恩禮
진종영%왕문도%여용%원응%리성리%양하%왕은례
超声检查%乳腺疾病%乳腺影像报告与数据系统
超聲檢查%乳腺疾病%乳腺影像報告與數據繫統
초성검사%유선질병%유선영상보고여수거계통
Ultrasonography%Breast diseases%BI-RADS
目的:探讨直径≤1 cm乳腺小肿块超声乳腺影像报告与数据系统(breast imaging reporting and data system ,BI‐RADS)的应用价值。方法参照超声BI‐RADS对219例患者共230个最大直径≤1 cm的小肿块进行描述与分级,评价超声BI‐RADS中所描述的各超声征象及最终分级和病理之间的关系。结果经病理证实良性肿块158个(687.%),恶性肿块72个(313.%)。超声BI‐RADS描述指标中形态、边缘、方向、后方回声及微钙化在良、恶性小肿块的差别具有统计学意义(P <0.05),形态不规则、边缘不清晰、方向垂直、后方回声衰减、微钙化为恶性征象,对恶性肿块诊断的阳性预测值为533.%~100%、敏感性为28.%~750.%、特异性为823.%~100%、准确性为696.%~809.%。评估为BI‐RADS 3、4、5级的小肿块分别有152个(661.%)、62个(270.%)、16个(70.%),恶性肿块诊断的阳性预测值分别为105.%(16/152)、645.%(40/62)、100%(16/16)。术前评估为BI‐RADS 3级而病理结果显示为恶性者中875.%(14/16)为导管内癌和特殊类型浸润性癌,良性小肿块术前诊断为BI‐RADS 4级的病例中909.%(20/22)为增生病和导管内乳头状瘤。结论直径≤1 cm的乳腺小肿块中,由于恶性征象敏感性不高、良恶性病变征象重叠及病理类型等影响,BI‐RADS 3级的阳性预测值偏高,故小肿块的超声BI‐RADS 分级有待进一步细化研究。
目的:探討直徑≤1 cm乳腺小腫塊超聲乳腺影像報告與數據繫統(breast imaging reporting and data system ,BI‐RADS)的應用價值。方法參照超聲BI‐RADS對219例患者共230箇最大直徑≤1 cm的小腫塊進行描述與分級,評價超聲BI‐RADS中所描述的各超聲徵象及最終分級和病理之間的關繫。結果經病理證實良性腫塊158箇(687.%),噁性腫塊72箇(313.%)。超聲BI‐RADS描述指標中形態、邊緣、方嚮、後方迴聲及微鈣化在良、噁性小腫塊的差彆具有統計學意義(P <0.05),形態不規則、邊緣不清晰、方嚮垂直、後方迴聲衰減、微鈣化為噁性徵象,對噁性腫塊診斷的暘性預測值為533.%~100%、敏感性為28.%~750.%、特異性為823.%~100%、準確性為696.%~809.%。評估為BI‐RADS 3、4、5級的小腫塊分彆有152箇(661.%)、62箇(270.%)、16箇(70.%),噁性腫塊診斷的暘性預測值分彆為105.%(16/152)、645.%(40/62)、100%(16/16)。術前評估為BI‐RADS 3級而病理結果顯示為噁性者中875.%(14/16)為導管內癌和特殊類型浸潤性癌,良性小腫塊術前診斷為BI‐RADS 4級的病例中909.%(20/22)為增生病和導管內乳頭狀瘤。結論直徑≤1 cm的乳腺小腫塊中,由于噁性徵象敏感性不高、良噁性病變徵象重疊及病理類型等影響,BI‐RADS 3級的暘性預測值偏高,故小腫塊的超聲BI‐RADS 分級有待進一步細化研究。
목적:탐토직경≤1 cm유선소종괴초성유선영상보고여수거계통(breast imaging reporting and data system ,BI‐RADS)적응용개치。방법삼조초성BI‐RADS대219례환자공230개최대직경≤1 cm적소종괴진행묘술여분급,평개초성BI‐RADS중소묘술적각초성정상급최종분급화병리지간적관계。결과경병리증실량성종괴158개(687.%),악성종괴72개(313.%)。초성BI‐RADS묘술지표중형태、변연、방향、후방회성급미개화재량、악성소종괴적차별구유통계학의의(P <0.05),형태불규칙、변연불청석、방향수직、후방회성쇠감、미개화위악성정상,대악성종괴진단적양성예측치위533.%~100%、민감성위28.%~750.%、특이성위823.%~100%、준학성위696.%~809.%。평고위BI‐RADS 3、4、5급적소종괴분별유152개(661.%)、62개(270.%)、16개(70.%),악성종괴진단적양성예측치분별위105.%(16/152)、645.%(40/62)、100%(16/16)。술전평고위BI‐RADS 3급이병리결과현시위악성자중875.%(14/16)위도관내암화특수류형침윤성암,량성소종괴술전진단위BI‐RADS 4급적병례중909.%(20/22)위증생병화도관내유두상류。결론직경≤1 cm적유선소종괴중,유우악성정상민감성불고、량악성병변정상중첩급병리류형등영향,BI‐RADS 3급적양성예측치편고,고소종괴적초성BI‐RADS 분급유대진일보세화연구。
Objective To evaluate the clinical value of ultrasound breast imaging reporting and data system (BI‐RADS) in small solid breast masses with diameter ≤1 cm. Methods The ultrasound features of 230 solid breast masses with diameter ≤ 1 cm were described by ultrasound BI‐RADS, the relationship between ultrasound features, BI‐RADS final assesment and pathology were analyzed. Results Of these 230 masses, 72 (31 3.% ) were pathologically confirmed to be malignant and 158 (68 7.% ) to be benign. The ultrasound BI‐RADS features of mass shape, margin, orientation, posterior acoustic features, and microcalcificaition were significantly different between malignant and benign masses( P < 0.05). Irregular shape, noncircumscribed, nonparallel orientation, postrior shadowing, microcalcifications were regarded as malignant ultrasound features, their positive predictive values(PPV), sensitivity, specificity and accuracy for malignancy were 53 3.% -100%, 2 8.% -75 0.%, 82 3.% -100%, 69 6.% -80 9.%, respectively. One hundred and fifty‐two(66.1% ), 62(27 0.% ), 16(7 0.% ) masses were classified into grade 3, 4, and 5, respectively. The PPV for grade 3, 4 and 5 were 10 5.%, 64 5.%, 100% respectively. Among BI‐RADS grade 3 cases, 87 5.%malignant masses were intraductal carcinoma in situ and special type of invasive cancer, among pathological benign BI‐RADS grade 4 masses, 90 9.% were hyperplasia and intraductal papilloma. Conclusions In small breast masses with diameter ≤ 1 cm, due to the sensitivity of malignant signs are not high, the overlap between signs of benign and malignant lesions, pathological type and other factors, the positive predictive value of BI‐RADS grade 3 is higher than criteria of American College of Radiology, so BI‐RADS classification requires further detailed study.